Innovator partners in India to collaborate on a new
class of proteins - Anticalins® to develop various
programs in Oncology and Ophthalmology.
German Biotech company making safer, effective and differentiated Novel drugs
Aagami identified right partners, and took them to
7 interested companies for Anticalins®
With focused efforts 3 companies moved to term
sheet level discussions. Aagami kept facilitating
and persevering. 2 companies remained for final
Aagami maintained its spirits and perseverance
knowing Indian ways of working; even when client
was ready to give up as per Western ways.
Finally co development partnership happened in
next few months with one company in Oncology.
Second company took more time and couple of
visits before signing co-development deal for
Client signed co-development deals with 2
companies in Oct and Dec 2013 respectively
Right companies, right advice, structure,
perseverance and commitment were the key
success factor. in making it happen.
Aagami proved highly influential in negotiations
for finalization of the deals due to deep
experience in business culture nuances of India.
It brought repeat and referral business to Aagami.